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Abstract
During last decades, changes have been observed in the frequency of different histological 
subtypes of lung cancer - one of the most common causes of morbidity and mortality - with a 
declining proportion of squamous cell carcinomas and an increasing proportion of 
adenocarcinomas, particularly in developed countries. This suggests the emergence of new 
etiological factors and mechanisms including those defining the lung microenvironment 
promoting tumor growth. Assuming that the lung is the main portal of entry for broadly used 
nanomaterials and their established pro-inflammatory propensities, we hypothesized that 
nanomaterials may contribute to changes facilitating tumor growth. Here we report that an acute 
exposure to single-walled carbon nanotubes (SWCNT) induces recruitment and accumulation of 
lung-associated myeloid-derived suppressor cells (MDSC) and MDSC-derived production of 
TGF-β resulting in up-regulated tumor burden in the lung. The production of TGF-β by MDSC 
requires their interaction with both SWCNT and tumor cells. We conclude that pulmonary 
exposure to SWCNT favors the formation of a niche that supports ingrowth of lung carcinoma in 
vivo via activation of TGF-β production by SWCNT-attracted and pre-sensitized MDSC.
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Introduction
Currently, lung cancer is one of the most common causes of morbidity and mortality, 
although in 1912, it was described as “one of the rarest forms of cancer” (1). It accounts for 
14% of all cancer diagnoses and up to 30% of all cancer deaths. It is the leading cause of 
cancer death in the developed world whereby carcinoma of the lung and bronchus is the 
most impactful compared to the other forms of cancer (2). Etiologically lung cancer is 
strongly associated with the environmental exposure, with tobacco smoking and industrial 
air pollution being the major risk factors. Two main types of pulmonary carcinoma related to 
the exposure to cigarette and industrial smoke are squamous cell carcinoma (SCC) and small 
cell neuroendocrine carcinoma. These tumors usually develop from bronchial mucosa of 
conductive airways, where smoke particles deposit and lead to carcinogenesis. With the 
current efforts towards smoking cessation and a better control of industrial smoke exhausts, 
one would expect a decline of lung cancer prevalence. Instead, the lung cancer incidence 
keeps increasing (3). Moreover, although incidence of SCC appears to have decreased, the 
incidence of another type of lung cancer – adenocarcinoma, has been escalating in 
industrially developed countries in contrast to still preserved prevalence of SCC in the 
developing countries and regions (4, 5). This tumor accounts for up to 50% of newly 
diagnosed lung cancer cases and the reasons for its recently increased incidence remain 
poorly defined. Although the most frequently observed histological type of lung cancer 
among smokers is SCC, among never smokers, adenocarcinomas are more frequent than 
SCC and comprise the majority of tumors (6). Over 75% of these malignancies develop 
from the deep portions of the lung (the acinar structures).
These epidemiological data suggest that entirely new, possibly environmental, factors got 
engaged in pulmonary carcinogenesis. One of possible candidates are nanoparticles (NP) 
with an estimated ~1,300 kinds of nanomaterials currently either in use or in testing for 
potential commercial applications ranging from electronic (e.g., advanced memory chips) to 
industrial (e.g., coatings or composites) to biomedical fields (e.g., drug delivery systems, 
diagnostics) (7). While the risk of adverse effects of nanomaterials on the human body has 
still to be investigated (8), their ability to induce robust inflammatory response and fibrosis 
have been firmly established (9-11). The highest risk arises from occupational exposure via 
chronic inhalation of NP. For instance, carbon nanotubes (CNT) could be released as dust 
into the atmosphere during disposal or lower temperature incineration of lithium-ion 
secondary batteries and synthetic textiles (12). It was estimated that there could be between 
20,000 to 100,000 natural and man-made NP per cubic centimeter in the everyday 
environment (13). Analysis of indoor and outdoor environmental NP revealed that their most 
significant fraction were carbonaceous NP, particularly CNT (14). Lung is the major entry 
portal and target organ for airborne CNT which can migrate into the alveolar interstitial 
compartment of the lung (9, 15). In contrast to tobacco smoke particulates, CNT - due to 
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their small size - can deposit deep in the lung and even reach the pleura (16). In spite of 
several enzymatic pathways for their biodegradation by inflammatory cells (17, 18), CNT 
are relatively biopersistent (19). Tragically, among 60,000-70,000 exposedresponders during 
the World Trade Center (WTC) disaster, generated as a result of the combustion of fuel in 
the presence of carbon and metals, CNT were found in the lungs of WTC patients suffering 
from pulmonary diseases (20).
Recently, we have demonstrated that a single pulmonary exposure to single-walled CNT 
(SWCNT) accelerated growth of lung cancer in mice (21). We further uncovered that 
depletion of CNT-induced accumulation of myeloid-derived suppressor cells (MDSC) 
prevented accelerated growth of lung carcinoma. However, the key question about 
molecular mechanisms of this phenomenon has not been established. Based on 
bioinformatics analysis of previously obtained proteomics (22) and transcriptomics data as 
well as existing known factors of MDSC recruitment/function and tumor initiation/growth/
progression/metastasis, we hypothesized that TGF-β is the most likely candidate for: (a) 
nanotubes-induced changes in the lung, (b) MDSC-mediated support of tumor growth, and 
(c) MDSC functioning in the tumor microenvironment. Therefore, we examined the role of 
aberrant TGF-β signaling on increased homing of MDSC and accelerated tumor progression 
upon SWCNT exposure.We report that CNT up-regulate TGF-β production by tumor-
activated MDSC and support immunosuppressive protumorigenic microenvironment in the 
lungs of CNT-exposed animals. Consequently, TGF-β-deficiency completely abrogated the 
CNT-induced acceleration of cancer growth in the lung. We provide evidence that CNT are 
required for upregulated production of TGF-β by MDSC induced by tumor cells. In turn, 
TGF-β produced by activated MDSC was responsible for suppression of T cell activation 
and proliferation. Overall, our results identify the airborne SWCNT as a potential risk factor 
of accelerated progression of lung carcinoma in vivo and uncovered immunological 
mechanisms underlying this effect.
Materials and Methods
Animals
Pathogen-free C57BL6/J mice (7–8 wk old) and Tgfb1tm1Doe/J mice from Jackson Labs (Bar 
Harbor, ME, USA) were individually housed and acclimated for 2 weeks. Animals were 
supplied with water and food ad libitum and housed under controlled light, temperature and 
humidity conditions. All animal studies were conducted under a protocol approved by the 
Institutional Animal Care and Use Committee.
Preparation of SWCNT
SWCNT (CNI Inc., Houston, TX) were produced by the high pressure CO 
disproportionation process (HiPco) technique employing CO in a continuous-flow gas phase 
as the carbon feedstock and Fe(CO)5 as the iron-containing catalyst precursor, and purified 
by acid treatment to remove metal contaminates. Chemical analysis trace metal (iron) in 
SWCNT was performed at the Chemical Exposure and Monitoring Branch (DART/NIOSH, 
Cincinnati, OH) using nitric acid dissolution and inductively coupled plasma-atomic 
emission spectrometry (ICP-AES) as described earlier (21). The mean diameter and surface 
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area of SWCNT were 1-4 nm and 1040 m2/g. Surface area was determined by Brunauer, 
Emmett and Teller (BET) analysis, and diameter and length was measured by transmission 
electron microscopy (TEM). The chemical cutting of SWCNT was performed as reported 
previously (21). TEM determined the length distribution: 228 ± 77 nm. Atomic force 
microscopy and diffuse reflectance infrared Fourier Transform spectroscopy were utilized to 
determine structure and purity of prepared SWCNT as described (21). Stock suspensions 
(1mg/ml) were prepared before each experiment in PBS and pH was adjusted to 7.0; 
suspensions were sonicated for 5 min and sterilized by autoclaving. Stock suspensions were 
diluted to achieve required concentrations and sonicated (three one-min cycles) before use.
Tumor cells, cell lines and experimental procedures
Lewis lung carcinoma cells (LLC) and BEAS-2B cells (human bronchial epithelial cell line), 
were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). LLC 
cells were maintained in RPMI 1640 medium supplemented with 2 mM L-glutamine, 100 
U/ml penicillin, 100 μg/ml streptomycin, 10 mM HEPES, 10% heat-inactivated FBS, 0.1 
mM nonessential amino acids, and 1 mM sodium pyruvate (Invitrogen Life Technologies, 
Inc, Grand Island, NY, USA). BEAS-2B cells were cultured in DMEM (5% FBS) and 
exposed to 0.06, 0.12, 0.24 mg/ml of SWCNT for 18h.
Wild type (WT) and TGF-β-deficient mice were exposed to CNT by pharyngeal aspiration 
(21), shown to induce alterations in the lungs similar to those caused by inhalation in special 
chambers (9). Briefly, after anesthesia with ketamine/xylazine (62.5 and 2.5 mg/kg s.c.), 
each mouse was placed on a board in a near-vertical position and a suspension of CNT (80 
μg/mouse in saline) was placed posterior in the throat to be aspirated into the lungs. Seven-
eight animals per group were utilized for the in vivo studies and all experiments were 
independently repeated at least three times. In control groups, both WT and TGF-β-deficient 
mice were exposed to a single aspiration of PBS.
Forty eight hours after CNT or PBS exposure, mice were inoculated with 3 × 105 LLC cells 
(300 μl PBS) via the tail vein. Twenty one days later, the animals were sacrificed and the 
number of visible pulmonary metastases was determined using a dissection microscope. 
Lungs were weighted, and right lobes were fixed in 10% formaldehyde for histopathology 
evaluation of H&E stained specimens (21).
Evaluation of MDSC
For pulmonary MDSC isolation and analysis (48 h after CNT exposure), mouse lungs were 
dispersed using 2% collagenase A and 0.75% DNAse I (Roche Diagnostics GmbH, 
Mannheim, Germany) in RPMI 1640 medium supplemented with 10% FBS at 20°C for 1 h. 
Spleens were harvested, grounded, and filtered through a 70 μm cell strainer. Red blood 
cells were lysed with lysing buffer (155 mM NH4Cl in 10 mM Tris-HCl buffer pH 7.5, 
25°C) for 3 min. After RBC lysis, cells were washed, labeled with anti-CD11b, anti-Ly6G, 
anti-Ly6C, anti-Gr-1 and anti-CD45 antibodies (Biolegend Inc., San Diego, CA, USA) 
directly conjugated to FITC, PE, PE/Cy7, APC/Cy7 or Alexa700, and analyzed by flow 
cytometry (BD LSR II instrument, BD Biosciences, San Jose, CA, USA). Data on MDSC 
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counts in the lung and spleen are presented as the percentage of total cells and CD45+ cells 
in the tested tissue.
CD11b+ Gr-1+ MDSC were isolated from the lungs of WT and TGF-β-deficient mice 
exposed to SWCNT or saline by magnetic cell sorting using a mouse MDSC Isolation Kit 
(MACS, Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer’s instructions. 
Syngeneic T cells were isolated from the spleens of WT mice using T cell enrichment 
columns and activated with ConA (5 h, 2.5 μg/ml, Sigma, St. Louis, MO, USA) for 24 h. For 
functional studies, isolated MDSC were co-cultured with pre-activated syngeneic splenic T 
cells (1:5 ratio) for 48 h and the levels of IL-2 production by T cells were assessed by 
ELISA (R&D Systems Inc., Minneapolis, MN). T cell proliferation was measured by uptake 
of 3H-thymidine (1 μCi/well, 5 Ci/mmol; DuPont-NEN, Boston, MA, USA) pulsed for 
16-18 h after two days in culture. Cells were harvested on GF/C glass fiber filters (Whatman 
Intl. Ltd, Maidstone, UK) using MACH III microwell harvester (Tomtec, Hamden, CT, 
USA). 3H-thymidine incorporation was determined on MicroBeta TRILUX liquid 
scintillation counter (WALLAC, Finland) and expressed as count per minute (cpm). 
Alterations of T cell proliferation by MDSC are shown as Index of Stimulation (IS) 
calculated as a ratio of treated to non-treated (control) T cells.
Production of TGF-β by MDSC was determined by assessing the levels of TGF-β1 in cell-
free supernatants by ELISA (R&D Systems, Minneapolis, MN, USA).
Bioinformatics based identification of CNT-induced and MDSC-mediated factors 
facilitating accelerated growth of lung cancer. The list of mediators that play a key role in 
MDSC recruitment/function was created based on the published data (23, 24). The list of 
genes encoding cytokines, chemokines and growth factors associated with tumor initiation/
progression/growth/ metastasis in lung cancer was generated through the use of IPA 
software tool (Ingenuity® Systems, www.ingenuity.com). Finally, the list of inflammatory 
mediators differentially up-regulated (>1.5 folds in at least two different concentrations) 
upon SWCNT exposure was composed based on the data obtained from microarray analysis 
studies of BEAS-2B cells.
High Density Oligonucleotide Array Expression Analysis
Total RNA from BEAS-2B cells cultured with medium or SWCNT were isolated using 
RNeasy (Qiagen, Valencia, CA). Further sample preparation for microarray analysis was 
carried out as described by the manufacturer (Affymetrix, Santa Clara, CA). Briefly, total 
RNA (12 μg) was used for the preparation of double stranded cDNA using an 
oligonucleotide (dT)24 primer with a T7 RNA polymerase promoter sequence at its 5' 
end.Following second strand synthesis, a labeled cRNA transcript was generated from the 
cDNA in an in vitro transcription (IVT) reaction using Enzo BioArray high yield RNA 
transcript labeling (Enzo Diagnostics Inc., Farmingdale, NY).The labeled antisense cRNA 
was purified using RNeasy (Qiagen) and each cRNA sample was fragmented (94°C for 35 
min) in the presence of Tris-acetate (40 mM, pH 8.1), potassium acetate (100 mM), and 
magnesium acetate (30mM).
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The fragmented cRNA was mixed with eukaryotic hybridization control oligonucleotides 
(20X; BioB, BioC, BioD, cre at 1.5, 5, 25 and 100 pM, respectively), control 
oligonucleotide B2, herring sperm DNA (10 mg/ml), acetylated BSA (50 mg/ml) and 
hybridization buffer (2X) to form the hybridization cocktail. This cocktail, was heated (99°C 
for 5 min; and 45°C for 5 min) prior to introduction to microarray cartridge (U133A). 
Hybridization was allowed to proceed (45°C in rotisserie oven set at 60 rpm) for 16 h. 
Following hybridization, the arrays were washed and stained using the GeneChip™ fluidics 
station protocol EukGE-WS2. Following washing and staining, probe arrays were scanned 
using Gene Array® 2500 scanner (Affymetrix). ImageGene 3.0 software (BioDiscovery 
Inc.) was used to quantify, correct for background noise and normalize signals from 
hybridization chip. Thus obtained data were filtered based on signal intensity and detection 
calls. To identify genes differentially expressed between control and SWCNT exposed 
groups, we used univariate F-test (after log2 conversion of the mRNA expression 
abundance, FPKM) between control and exposed groups with a p value cut off of 0.05 and 
false discovery rate below 0.05 using statistical package R.
Statistical analysis
Results were analyzed using one-way ANOVA and Student unpaired t-test with Welch's 
correction for unequal variances. All experiments were repeated at least twice and the results 
are presented as the means ± SEM. P values of < 0.05 were considered to be statistically 
significant.
Results
Bioinformatics analysis of inflammatory mediators common to CNT exposure and MDSC-
driven immuno-suppression in lung cancer
Multifactorial processes of tumor progression and metastasis are strongly associated with 
chronic inflammation whereby several cytokines, chemokines and growth factors produced 
by cancer cells as well as modified immune cells, including MDSC, play essential roles. 
Based on the available literature we used bioinformatics to generate lists of key cytokines, 
chemokines and growth factors associated with (a) MDSC recruitment and function, (b) 
initiation, progression, metastasis and growth of lung tumors, and (c) SWCNT exposures as 
summarized on Figure 1. A total of three factors – macrophage colony stimulating factor 
(M-CSF), granulocyte/macrophage colony stimulating factor (GM-CSF), andTGF-β - were 
common to all three selected categories. This analysis suggests that the up-regulation of 
GM-CSF, M-CSF and TGF-β upon SWCNT exposure may lead to increased accumulation 
of MDSC in the lung and accelerated growth of lung cancer. To explore mechanisms of 
CNT in pulmonary metastatic tumor growth, we chose to experimentally assess the effects 
of TGF-β.
Accelerated tumor growth induced by SWCNT is blocked in TGF-β-deficient mice
Injection of LLC cells to control WT mice caused multiple bilateral pulmonary tumor 
nodules by day 21. Histologically, these tumors showed characteristic features of poorly-
differentiated non-small cells carcinoma. Exposure of WT mice to SWCNT prior to tumor 
cell injection resulted in significant acceleration of tumor growth revealed by up to 5-fold 
Shvedova et al. Page 6













increase in the weight of the lungs (the overall tumor burden), up to 2.5-fold elevation of the 
number of visible pulmonary macro-metastasis, and up to 3-fold increase in the total area of 
tumor nodules upon histopathological evaluation of the lung tissues (Fig.2, p<0.05). 
SWCNT did not change the typical morphological features of tumor, but accelerated tumor 
growth and the appearance of intratumoral necrosis zones, associated with rapid tumor 
growth.
In control TGF-β-deficient mice, injection of LLC cells led to the appearance of pulmonary 
metastases, similar in size and morphology to those in WT mice (Fig.2a, b, c). However, the 
effect of CNT on tumor growth was completely abrogated in TGF-β-deficient animals: 
neither the average lung weight (Fig.2a), nor the numbers of detectable tumor nodules (Fig.
2b) were altered in TGF-β-deficient mice after exposure to CNT. Histopathological 
examination of H&E stained tissue specimens confirmed the absence of difference in the 
total area of tumor nodules between CNT-exposed and saline-exposed TGF-β-deficient mice 
receiving tumor cells after exposure (Fig.2c). These data indicate that exposure of SWCNT 
promoted establishment and growth of lung carcinoma in mice in vivo in a TGF-β-dependent 
manner.
TGF-β deficiency does not abrogate acute accumulation of MDSC in the lung after a single 
pulmonary exposure to SWCNT
Because depletion of MDSC induced by CNT exposure prior to administration of tumor 
cells completely abrogated increase in lung cancer growth (21), it is likely that MDSC may 
form the premalignant niches supporting initial survival and growth of tumor cells in the 
lungs. Assuming that MDSC contribute to TGF-β-mediated metastasis (25), it is possible 
that CNT may induce early MDSC accumulation in TGF-β-deficient mice. To test this, we 
determined the accumulation of MDSC in the lungs 48 h after SWCNT aspiration because 
the elimination of this acute MDSC response in TGF-β-deficient animals might explain the 
abrogation of the tumor-promoting activity of CNT in Tgfb1tm1Doe mice shown in Figure 2. 
However, the results showed that TGF-β is not involved in the initial recruitment of MDSC 
in the lungs and lymphoid tissues by acute SWCNT exposure (Fig.3). In fact, similar to WT 
mice (21), SWCNT significantly (p<0.05) up-regulated homing of granulocytic MDSC in 
lymphoid and non-lymphoid tissues in TFG-β-deficient animals: elevated up to 3-fold 
numbers of CD11b+Ly6G+Ly6Clow MDSC were detected in the lungs and spleens of 
SWCNT-treated tumor-free animals 48 h after CNT administration (Fig.3a,b). These data 
indicate that TGF-β was not involved in SWCNT-induced recruitment of MDSC to the lungs 
to form the premalignant niches. Thus, TGF-β plays a different role – possibly participating 
in MDSC functions facilitating CNT-induced enhanced growth of lung carcinoma.
SWCNT pre-sensitize MDSC to tumor-induced activation of the TGF-β-mediated immune 
suppressive activity
One of the potential – although not fully characterized – immunosuppressive mechanisms of 
MDSC is the production of TGF-β (26, 27). To assess the role of MDSC-derived TGF-β in 
CNT-induced MDSC-mediated immunosuppressive premalignant niche in the lung, 
pulmonary MDSC were isolated from control and SWCNT-exposed WT and Tgfb1tm1Doe 
mice, treated with control and LLC-conditioned media, co-cultured with pre-activated 
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syngeneic T cells, and then T cell activity was assessed by IL-2 production (Fig. 4a). 
Analysis of MDSC-mediated inhibition of T cell activation (Fig. 4b) reveled that only 
MDSC harvested from WT SWCNT-exposed mice, but not from saline-exposed mice, and 
pre-incubated with tumor-conditioned medium were able to suppress T cells ex vivo up to 2-
fold (p<0.05). Importantly, the immunosuppressive effect of MDSC was abrogated if they 
were isolated from TGF-β-deficient mice. These results suggest that MDSC exposed to the 
SWCNT-modified lung microenvironment for even less than 48 h in vivo are sensitive to 
lung carcinoma-induced emergence of the immunosuppressive potential mediated by TGF-β.
Although these results provide strong evidence that tumor-derived factors play a key role in 
activating the immunosuppressive phenotype of CNT-pre-sensitized MDSC, they were 
based on the in vitro treatment of MDSC with the LLC-conditioned medium. To explore the 
in vivo role of tumor cells in activating pulmonary MDSC, we further isolated MDSC from 
saline- and SWCNT- exposed mice bearing lung cancer. Tumor-free mice served as a 
control. The design and results of these studies are shown in Figure 5 and demonstrate that 
in vivo generated lung MDSC required in vivo interaction with tumor cells to acquire an 
immunosuppressive phenotype assessed by their ability to suppress proliferation of 
syngeneic T cells. Furthermore, the ability of MDSC to inhibit T cells was aborted if 
pulmonary MDSC were harvested from TGF-β-deficient animals (Fig.5, p<0.05). Together, 
the in vitro and in vivo data suggest that MDSC attracted to the lungs by SWCNT exposure 
are more sensitive to the activation in the lung cancer microenvironment than control 
pulmonary MDSC, and that the ability of lung MDSC to inhibit T cells is mediated by TGF-
β.
This encouraged us to further examine direct effects of CNT on MDSC and TGF-β 
production by MDSC. To this end, MDSC were directly treated with SWCNT in vitro and 
TGF-β1 expression was evaluated. We found that, although CNT and LLC did not markedly 
increased TFG-β levels in MDSC cultures (189.2±19.6 ng/ml vs 201.1±18.2 ng/ml and 
229.4±24.4 ng/ml in control, CNT-treated and LLC-treated cells, respectively), concomitant 
treatment of MDSC with SWCNT and LLC-conditioned medium significantly increased 
TGF-β in MDSC cultures (313.7±21.2 ng/ml, p<0.05) (Figure 6). Thus, SWCNT augment 
TGF-β expression by MDSC induced by lung cancer cells.
Overall, we established a potential mechanism of CNT-induced enhanced growth of lung 
carcinoma, which is mediated by an immediate recruitment and accumulation of MDSC in 
the lungs and formation of specific microenvironmental niches that support tumor cell 
growth. Although TGF-β was not involved in the initial recruitment of MDSC to the lung by 
SWCNT, its deficiency completely blocked accelerated tumor progression in the lungs after 
SWCNT exposure. CNT-triggered changes in the lung microenvironment encouraged 
accumulation of MDSC that were sensitive to tumor-induced activation leading to TGF-β-
dependent suppression of T cells.
Discussion
A huge diversity of carbonaceous nanomaterials is on the way to multiple industrial and 
biomedical applications; therefore, understanding their toxicity is critical for their 
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commercialization (28). Among those, CNT have been reported to have several adverse 
effects on cellular and organismal levels, which may be predictive of detrimental human 
health effects upon exposures (29-31). For instance, in vitro studies indicate that single- and 
multi-walled CNT may be genotoxic, demonstrating a potential carcinogenic potential. 
Chronic exposure to CNT was shown to induce DNA damage and increase mutation 
frequency in mouse embryonic cells and human epithelial cells (32, 33). CNT induce mitotic 
abnormality with one rather than two mitotic spindle poles, a potential mechanism the 
impaired cell division (34). Many studies have reported that CNT can induce apoptosis, 
DNA damage, and activation of major regulatory pathways - MAPKs, AP-1, NF-κB, and 
Akt - all of which recapitulate key molecular events involved in asbestos-induced lung 
cancer (31, 35). Moreover, Pacurari et al. reported that MWCNT exposure affects a subset 
of lung cancer prognostic biomarkers in mouse lungs (36) and Wang et al. showed that 
chronic exposure to SWCNT in vitro caused malignant transformation of human lung 
epithelial cells (37).
In the context of tumorogenesis and tumor/host relationships, important are the effects of 
CNT on pulmonary microenvironment. Several animal studies demonstrated that exposure 
to CNT induced acute and chronic inflammatory response, chronic granulomatous reaction 
and substantial interstitial fibrosis in the lungs (9, 11, 16, 29, 30). Fibrosis may be viewed as 
a precursor to lung cancer. In fact, pulmonary scarring and lung cancer were found to occur 
to the same lung regions and extend over time, indicating that lung cancer could originate 
from lung scarring (38). Overall, there are two potential pro-tumorigenic mechanisms 
associated with CNT exposure: i) direct carcinogenic effects on pulmonary cells and ii) 
alteration of inflammatory pulmonary milieu making it conducive to cancer development. 
Surprisingly, the second mechanism - acute CNT effects on host-tumor interactions and 
growth of tumors has not been yet considered.
Previously we have reported that CNT promote tumor establishment and lung tumor growth 
by altering the tissue microenvironment, specifically by facilitating early MDSC 
accumulation in the lungs, as depletion of MDSC abrogated pro-tumor effect of acute 
exposure to CNT (21). It is likely that inflammatory MDSC induced by CNT support the 
initial tumor cell homing in the lung and then become polarized into tumor-associated 
MDSC. The latter are known to block the development of antitumor immunity hence 
facilitate tumor growth by producing specific growth factors and cytokines that also 
stimulate intratumoral neoangiogenesis (39). However, the specific mechanisms through 
which SWCNT affect MDSC-tumor cell interactions and induce immunosuppressive 
activity have not been deciphered. Bioinformatics analysis of previously published data 
revealed that 3 growth factors, GM-CSF, G-CSF, and TGF-β are common to CNT, 
formation, progression of lung cancer, and accumulation and immunosuppressive function 
of MDSC (Fig. 1). These growth factors have been shown to be expressed in tumor lesions 
(40). While M-CSF stimulates the differentiation of granulocytes or macrophages (41), GM-
CSF and TGF-β have been reported to have a strong impact on MDSC expansion (40, 42, 
43). Thus it is possible that all three of the factors - GM-CSF, M-CSF and TGF-β - are 
involved in the accelerated tumor growth after SWCNT exposure. Notably, TGF-β has been 
identified as a metastasis promoter (44). Given a recently reported up-regulation of TGF-β in 
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the lungs of mice after chronic inhalation of multiwalled CNT (45), we speculated that TGF-
β could be responsible for the increased homing of MDSC and accelerated tumor 
progression responses upon SWCNT exposure.
Here we uncovered the key function of TGF-β in SWCNT-induced and MDSC-mediated 
formation of premalignant niches and acceleration of lung carcinoma establishment in vivo 
(Fig. 2). TGF-β is involved in many biological processes, including cell proliferation, 
differentiation, apoptosis, embryogenesis as well as cancer (46, 47). Alterations in TGF-β 
signaling have significant effects on tumor initiation and progression (46) and the lack of 
TGF-β signaling may promote collective cancer cell invasion and tumor progression (48). 
One of the identified mechanisms of TGF-β-dependent tumor promotion is the recruitment 
of MDSC to the tumor microenvironment (25). TGF-β is also an important suppressive 
cytokine produced by MDSC for inhibiting the antitumor immunity (26). TGF-β may also 
suppress VEGF-mediated angiogenesis in cancer metastasis (49). Several reports showed 
that blocking of TGF-β by an antibody or soluble receptor inhibited tumor growth (50-52). 
Moreover, TGF-β can suppress antitumor immune responses and create a local environment 
of immune tolerance (46). Elevated levels of serum TGF-β1 and its association with 
metastases were independently detected in patients with different types of cancer (53). 
Further, in lung cancer, increased expression of TGF-β was correlated with advanced stages 
of disease malignancy, metastases with decreased survival rates (54). There are several 
mechanisms through which TGF-β can accelerate growth of lung carcinoma. Up-regulated 
levels of TGF-β upon SWCNT exposure could (a) participate directly in recruiting/
expanding MDSC, (b) contribute to the suppression of T-cell responses by activating/
differentiating MDSC to secrete IL-10 and TGF-β, (c) contribute to indirect suppression by 
inducing Tregs through membrane binding on MDSC (39, 55). However, the mechanisms of 
induction of TGF-β expression and the source of this cytokine in tumor models have not 
been understood, except for the fact that tumor cells are known to produce this cytokine.
Here, we show that TGF-β is not involved in the initial recruitment and accumulation of 
MDSC to the lungs induced by SWCNT (Fig. 3), although TGF-β deficiency abrogates the 
pro-tumor effect of CNT mediated by MDSC. This suggests that TGF-β released by MDSC 
in the lung may be involved in CNT-induced up-regulation of tumor growth. 
Experimentally, this has been examined using the ex vivo model systems where MDSC 
isolated from control and CNT-exposed mice were treated with LLC-conditioned medium 
and then tested for their ability to suppress proliferation of T lymphocytes. We demonstrated 
that the in vivo exposure to SWCNT rendered lung MDSC sensitive to tumor-induced 
expression of TGF-β, which was responsible for the inhibition of T cell activity by MDSC. 
This was further supported by the results obtained in another ex vivo model where MDSC 
were harvested from tumor-bearing CNT-exposed mice and shown to inhibit T cell 
proliferation in TGF-β-dependent manner. In our tumor model, although LLC cells can 
produce TGF-β, this source of the cytokine cannot play a critical role in the negative 
regulation of tumor immunosurveillance because LLC-bearing TGF-β deficient mice were 
resistant to SWCNT-induced acceleration of tumor establishment. Considering that TGF-β 
produced by CD11b+Gr-1+ cells is necessary for down-regulation of cytotoxic T cell-
mediated tumor immunosurveillance (27) and our data demonstrating direct effect of CNT 
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on tumor-induced TGF-β production by MDSC, our combined findings uncovered a new 
pathway through which acute pulmonary exposure to CNT changes the interaction between 
myeloid regulatory cells and malignant cells to benefit tumor growth and metastasis in vivo.
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Figure 1. Venn diagram of cytokines, chemokines and growth factors that (I) affect MDSC 
generation, recruitment, expansion and function, (II) facilitate lung cancer growth, progression 
and metastasis; (III) are upregulated (>1.5 folds) upon SWCNT exposure
The list of mediators that play a key role in MDSC recruitment/function was created based 
on the published data (23, 24). The list of genes encoding cytokines, chemokines and growth 
factors associated with tumor initiation/progression/growth/ metastasis in lung cancer was 
generated through the use of IPA software tool (Ingenuity® Systems, www.ingenuity.com). 
Finally, the list of inflammatory mediators differentially up-regulated (>1.5 folds in at least 
two different concentrations) upon SWCNT exposure was composed based on the data 
obtained from microarray analysis studies of BEAS-2B cells.
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Figure 2. TGF-β deficiency aborts SWCNT-induced accelerated growth of lung carcinoma
Wild type (WT) and TGF-β-deficient (TGF-β def) mice received SWCNT by pharyngeal 
aspiration 48 h prior to i.v. tumor cell injection and sacrificed 3 weeks later. The lungs were 
collected for determining the weight (a), visualization of macroscopic tumor nodules (b), 
and histochemical analysis of micrometastases after H&E staining (c). The average weight 
of the lungs, the number of tumor nodules, and the average collective areas of lung 
carcinoma on tissue slides were calculated from 3 independent experiments (5-6 mice/group 
in each) and are shown for LLC and CNT/LLC groups in both WT and TGF-β-deficient 
mice. LLC, mice received a single aspiration of PBS and 48 h later were injected i.v. with 
LLC tumor cells; CNT/LLC, mice were pre-treated with SWCNT 48 h prior to 
administration of LLC cells. *, p<0.05 (Student t-test, N=3).
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Figure 3. TGF-β deficiency does not abrogate acute accumulation of MDSC in the lung and 
spleen after a single pulmonary exposure to SWCNT
Wild type (WT) and Tgfb1tm1Doe mice received SWCNT by pharyngeal inhalation and the 
levels of monocytic CD11b+Ly6GnegLy6Chigh (area 1) and granulocytic 
CD11b+Ly6G+Ly6Clow/neg (area 2) MDSC were assessed by flow cytometry in the 
lymphoid tissues and lungs. The results of flow cytometry analysis of MDSC accumulation 
in tumor-free Tgfb1tm1Doe mice 48h after SWCNT aspiration are shown from a 
representative experiment (a) (CD11b+ gated cells are shown). Statistical analysis of data 
from 3 independent experiments (5-6 mice/group in each) is shown as the mean ± SEM and 
demonstrates accumulation of polymorphonuclear MDSC in different tissues in tumor-free 
mice 48 h after SWCNT aspiration. *, p<0.05 (Student t-test, N=3) (b). Control, mice 
received a single aspiration of PBS. CNT, mice received SWCNT once by pharyngeal 
inhalation.
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Figure 4. TGF-β mediates inhibition of T cells by lung MDSC isolated from SWCNT-exposed 
mice and treated with lung cancer-derived factors in vitro
Experimental protocol (a): WT and Tgfb1tm1Doe mice received SWCNT or saline by 
pharyngeal inhalation and 48 h later MDSC were isolated from the lungs as described in 
Materials and Methods. MDSC were then treated with LLC-conditioned medium and 
control medium for 24 h, washed and co-cultured with ConA pre-activated syngeneic T 
cells. Inhibition of T cell activation was determined in 48 h by assessing the levels of IL-2 in 
cell-free supernatants by ELISA (b). The results are shown as the mean ± SEM (triplicate 
measurements for each mouse, 5-6 mouse/group, two independent experiments). *, p<0.05 
versus all other groups (one-way ANOVA). Control (cntr), MDSC from saline-treated mice; 
CNT, MDSC from SWCNT exposed mice; Tum, MDSC treated with LLC-conditioned 
medium; T cells, control T cells cultured w/o MDSC.
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Figure 5. SWCNT predispose pulmonary tumor-associated MDSC to inhibit T cell proliferation 
via TGF-β1 pathways in vivo
Experimental protocol (a): WT and Tgfb1tm1Doe mice received SWCNT or saline by 
pharyngeal inhalation and LLC cells i.v. 48 h later. MDSC were isolated from the lungs 2 
weeks later and co-cultured with ConA pre-activated syngeneic T cells. Inhibition of T cell 
proliferation was determined in 48 h by 3H-thymidine incorporation and expressed as Index 
of Stimulation (b). The results are shown as the mean ± SEM (triplicate measurements for 
each mouse, 5 mouse/group, N=2). *, p<0.05 versus all other groups (one-way ANOVA). 
Control (cntr), saline inhalation; CNT, SWCNT inhalation; Tum, injection of LLC; T cells, 
control T cells cultured w/o MDSC.
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Figure 6. Exposure of MDSC to SWCNT and tumor-derived factors up-regulates TGF-β 
expression
MDSC were isolated from the bone marrow and cultured with saline (cntr), SWCNT (6.25 
μg/ml), LLC conditioned medium (25% v/v) overnight. MDSC were then collected, washed 
and cultured for 24 h. The levels of TGF-β1 in cell-free medium were assessed by ELISA.*, 
p<0.05 vs cntr (ANOVA, triplicate wells, N=3).
Shvedova et al. Page 20
Cancer Res. Author manuscript; available in PMC 2016 April 15.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
